相关实验视频
Updated: Sep 19, 2025

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
临床进展说明: 肺炎球菌病
Elizabeth L Nguyen1, Preeti Mehrotra2, Marie E Wang1
1Division of Pediatric Hospital Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
肺炎链球菌会引起严重的疾病,但肺炎球菌疫苗已经显著降低了疾病发病率. 医院医生是治疗患者和确保疫苗资格的关键.
科学领域:
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 肺炎链球菌是可预防的疾病和死亡的主要原因.
- 它会引起各种感染,从耳部感染到脑膜炎.
- 自2000年以来,肺炎球菌疫苗已经大大减少了疾病发病率.
研究的目的:
- 为了突出肺炎球菌疫苗的影响.
- 强调医院医生在患者护理和疫苗接种中的作用.
主要方法:
- 在Streptococcus pneumoniae流行病学上的文献综述.
- 对疫苗对疾病趋势的影响分析.
- 审查医院医师在传染病管理中的责任.
主要成果:
- 肺炎球菌联合疫苗的引入导致疾病的显著下降.
- 疫苗对100多种血清型的子集有效.
- 医院医生对于治疗肺炎球菌感染和确定疫苗接种需求至关重要.
结论:
- 肺炎球菌疫苗是高度有效的公共卫生干预措施.
- 持续的警和疫苗接种工作至关重要.
- 医院医生在控制肺炎球菌病和促进疫苗接种方面发挥着至关重要的作用.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
相关概念视频
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation